Stonebridge Capital Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-605
| Closed | -$60K | – | 966 |
|
|
2019
Q3 | $60K | Sell |
605
-22,462
| -97% | -$2.13M | 0.01% | 298 |
|
|
2019
Q2 | $2.13M | Sell |
23,067
-2,705
| -10% | -$257K | 0.38% | 74 |
|
|
2019
Q1 | $2.43M | Sell |
25,772
-938
| -4% | -$82K | 0.45% | 68 |
|
|
2018
Q4 | $1.71M | Sell |
26,710
-3,822
| -13% | -$282K | 0.4% | 72 |
|
|
2018
Q3 | $2.73M | Sell |
30,532
-165
| -0.5% | -$14.6K | 0.55% | 61 |
|
|
2018
Q2 | $2.44M | Buy |
30,697
+17,455
| +132% | +$1.45M | 0.53% | 61 |
|
|
2018
Q1 | $1.18M | Buy |
13,242
+1,700
| +15% | +$163K | 0.27% | 89 |
|
|
2017
Q4 | $1.21M | Sell |
11,542
-195
| -2% | -$22K | 0.28% | 87 |
|
|
2017
Q3 | $1.71M | Sell |
11,737
-335
| -3% | -$45.6K | 0.42% | 73 |
|
|
2017
Q2 | $1.57M | Buy |
12,072
+260
| +2% | +$31.9K | 0.41% | 76 |
|
|
2017
Q1 | $1.47M | Buy |
11,812
+40
| +0.3% | +$4.79K | 0.4% | 80 |
|
|
2016
Q4 | $1.36M | Sell |
11,772
-945
| -7% | -$105K | 0.4% | 81 |
|
|
2016
Q3 | $1.33M | Buy |
12,717
+490
| +4% | +$53K | 0.42% | 82 |
|
|
2016
Q2 | $1.21M | Buy |
12,227
+945
| +8% | +$97.8K | 0.41% | 82 |
|
|
2016
Q1 | $1.13M | Buy |
11,282
+345
| +3% | +$35.5K | 0.4% | 82 |
|
|
2015
Q4 | $1.31M | Buy |
10,937
+1,497
| +16% | +$173K | 0.48% | 70 |
|
|
2015
Q3 | $1.02M | Buy |
9,440
+935
| +11% | +$116K | 0.41% | 75 |
|
|
2015
Q2 | $984K | Buy |
8,505
+575
| +7% | +$65.7K | 0.38% | 80 |
|
|
2015
Q1 | $914K | Buy |
7,930
+2,755
| +53% | +$329K | 0.35% | 81 |
|
|
2014
Q4 | $579K | Buy |
5,175
+605
| +13% | +$63.8K | 0.24% | 97 |
|
|
2014
Q3 | $433K | Buy |
4,570
+1,200
| +36% | +$108K | 0.19% | 106 |
|
|
2014
Q2 | $289K | Sell |
3,370
-90
| -3% | -$6.84K | 0.13% | 118 |
|
|
2014
Q1 | $242K | Buy |
+3,460
| New | +$274K | 0.12% | 123 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Stonebridge Capital Advisors's CELG Position: Q4 2019 in Review
Stonebridge Capital Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 605 shares — an estimated $60K sold.
Stonebridge Capital Advisors first reported a position in CELG in Q1 2014 and held it in 23 quarters. The position peaked at $2.73M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Stonebridge Capital Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Stonebridge Capital Advisors sold 605 Celgene Corp shares in Q4 2019, an estimated $60K.
- Stonebridge Capital Advisors first reported a position in Celgene Corp in Q1 2014 and held it in 23 quarters.
- Stonebridge Capital Advisors's Celgene Corp position peaked at $2.73M in Q3 2018.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Stonebridge Capital Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.